What Was The Reason Behind BioLineRx (BLRX) Stock Increasing 8% In Extended Session?
The pre-commercial stage biopharmaceutical business BioLineRx Ltd. (NASD: BLRX) has increased 8.35% at $0.75 in after-hours trading hours on the latest check Friday after providing a corporate and portfolio update. What kind of update has BLRX given? When presenting its financial results this month, BioLineRx (BLRX) also gave business and portfolio updates. The conclusion of […]